🎉 M&A multiples are live!
Check it out!

Jiangsu Nhwa Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jiangsu Nhwa and similar public comparables like Pharming, Vivoryon Therapeutics, and Galapagos.

Jiangsu Nhwa Overview

About Jiangsu Nhwa

Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in manufacturing of APIs and dosages.


Founded

2007

HQ

China
Employees

1.6K+

Website

nhwa-group.com

Financials

LTM Revenue $817M

LTM EBITDA $202M

EV

$2.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Jiangsu Nhwa Financials

Jiangsu Nhwa has a last 12-month revenue of $817M and a last 12-month EBITDA of $202M.

In the most recent fiscal year, Jiangsu Nhwa achieved revenue of $785M and an EBITDA of $204M.

Jiangsu Nhwa expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Jiangsu Nhwa valuation multiples based on analyst estimates

Jiangsu Nhwa P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $695M $785M XXX XXX XXX
Gross Profit $452M $506M XXX XXX XXX
Gross Margin 65% 64% XXX XXX XXX
EBITDA $184M $204M XXX XXX XXX
EBITDA Margin 27% 26% XXX XXX XXX
Net Profit $124M $143M XXX XXX XXX
Net Margin 18% 18% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Jiangsu Nhwa Stock Performance

As of April 15, 2025, Jiangsu Nhwa's stock price is CNY 22 (or $3).

Jiangsu Nhwa has current market cap of CNY 22.3B (or $3.1B), and EV of CNY 18.6B (or $2.6B).

See Jiangsu Nhwa trading valuation data

Jiangsu Nhwa Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.6B $3.1B XXX XXX XXX XXX $0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Jiangsu Nhwa Valuation Multiples

As of April 15, 2025, Jiangsu Nhwa has market cap of $3.1B and EV of $2.6B.

Jiangsu Nhwa's trades at 3.1x LTM EV/Revenue multiple, and 12.7x LTM EBITDA.

Analysts estimate Jiangsu Nhwa's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Jiangsu Nhwa and 10K+ public comps

Jiangsu Nhwa Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.6B XXX XXX XXX
EV/Revenue 3.3x XXX XXX XXX
EV/EBITDA 12.5x XXX XXX XXX
P/E 19.5x XXX XXX XXX
P/E/Growth 1.3x XXX XXX XXX
EV/FCF 39.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Jiangsu Nhwa Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Jiangsu Nhwa Valuation Multiples

Jiangsu Nhwa's NTM/LTM revenue growth is 14%

Jiangsu Nhwa's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Jiangsu Nhwa's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Jiangsu Nhwa's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Jiangsu Nhwa and other 10K+ public comps

Jiangsu Nhwa Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 13% XXX XXX XXX XXX
EBITDA Margin 26% XXX XXX XXX XXX
EBITDA Growth 11% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 40% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 28% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 50% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Jiangsu Nhwa Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Jiangsu Nhwa M&A and Investment Activity

Jiangsu Nhwa acquired  XXX companies to date.

Last acquisition by Jiangsu Nhwa was  XXXXXXXX, XXXXX XXXXX XXXXXX . Jiangsu Nhwa acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Jiangsu Nhwa

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Jiangsu Nhwa

When was Jiangsu Nhwa founded? Jiangsu Nhwa was founded in 2007.
Where is Jiangsu Nhwa headquartered? Jiangsu Nhwa is headquartered in China.
How many employees does Jiangsu Nhwa have? As of today, Jiangsu Nhwa has 1.6K+ employees.
Is Jiangsu Nhwa publicy listed? Yes, Jiangsu Nhwa is a public company listed on SHE.
What is the stock symbol of Jiangsu Nhwa? Jiangsu Nhwa trades under 002262 ticker.
When did Jiangsu Nhwa go public? Jiangsu Nhwa went public in 2008.
Who are competitors of Jiangsu Nhwa? Similar companies to Jiangsu Nhwa include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Jiangsu Nhwa? Jiangsu Nhwa's current market cap is $3.1B
What is the current revenue of Jiangsu Nhwa? Jiangsu Nhwa's last 12-month revenue is $817M.
What is the current EBITDA of Jiangsu Nhwa? Jiangsu Nhwa's last 12-month EBITDA is $202M.
What is the current EV/Revenue multiple of Jiangsu Nhwa? Current revenue multiple of Jiangsu Nhwa is 3.1x.
What is the current EV/EBITDA multiple of Jiangsu Nhwa? Current EBITDA multiple of Jiangsu Nhwa is 12.7x.
What is the current revenue growth of Jiangsu Nhwa? Jiangsu Nhwa revenue growth between 2023 and 2024 was 13%.
Is Jiangsu Nhwa profitable? Yes, Jiangsu Nhwa is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.